G protein-coupled receptor kinase 4 role in hypertension

Hypertension

Volumn 65, Issue 6, 2015, Pages 1148-1155

  Yang, Jian ^a   Villar, Van Anthony M ^b   Jones, John E ^b   Jose, Pedro A ^b,c   Zeng, Chunyu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Division of Nephrology   (China)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DOPAMINE; G PROTEIN COUPLED RECEPTOR KINASE 4; ISOPROTEIN; REACTIVE OXYGEN METABOLITE; RGS PROTEIN; G PROTEIN COUPLED RECEPTOR; GRK4 PROTEIN, HUMAN;

ARTERY; BLOOD PRESSURE REGULATION; ESSENTIAL HYPERTENSION; GENE CONTROL; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INFLAMMATION; KIDNEY; LIGAND BINDING; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD PRESSURE MEASUREMENT; DISEASE COURSE; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HYPERTENSION; MALE; METABOLISM; MOUSE; PHARMACOGENETICS; PREDICTIVE VALUE; RAT; ROLE PLAYING; SEVERITY OF ILLNESS INDEX;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; DISEASE PROGRESSION; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; MALE; MICE; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RATS; RECEPTORS, G-PROTEIN-COUPLED; ROLE; SEVERITY OF ILLNESS INDEX;

EID: 84938099153     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05189     Document Type: Review

References (73)

1. Herrera M, Coffman TM. The kidney and hypertension: novel insights from transgenic models. Curr Opin Nephrol Hypertens. 2012;21:171-178. doi: 10.1097/MNH.0b013e3283503068.
2. Shirai A, Yamazaki O, Horita S, Nakamura M, Satoh N, Yamada H, Suzuki M, Kudo A, Kawakami H, Hofmann F, Nishiyama A, Kume H, Enomoto Y, Homma Y, Seki G. Angiotensin II dose-dependently stimulates human renal proximal tubule transport by the nitric oxide/guanosine 3',5'-cyclic monophosphate pathway. J Am Soc Nephrol. 2014;25:1523-1532. doi: 10.1681/ASN.2013060596.
3. Harris RC, Zhang MZ. Dopamine, the kidney, and hypertension. Curr Hypertens Rep. 2012;14:138-143. doi: 10.1007/s11906-012-0253-z.
4. Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature. 2009;459:356-363. doi: 10.1038/ nature08144.
5. Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular signatures of G-protein-coupled receptors. Nature. 2013;494:185-194. doi: 10.1038/nature11896.
6. Belmonte SL, Blaxall BC. G protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ Res. 2011;109:309-319. doi: 10.1161/CIRCRESAHA.110.231233.
7. Zeng C, Villar VA, Eisner GM, Williams SM, Felder RA, Jose PA. G proteincoupled receptor kinase 4: role in blood pressure regulation. Hypertension. 2008;51:1449-1455. doi: 10.1161/HYPERTENSIONAHA.107.096487.
8. Rayner B, Ramesar R, Steyn K, Levitt N, Lombard C, Charlton K. G-protein-coupled receptor kinase 4 polymorphisms predict blood pressure response to dietary modification in Black patients with mild-to-moderate hypertension. J Hum Hypertens. 2012;26:334-339. doi: 10.1038/ jhh.2011.33.
9. Bhatnagar V, O'Connor DT, Brophy VH, Schork NJ, Richard E, Salem RM, Nievergelt CM, Bakris GL, Middleton JP, Norris KC, Wright J, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS; AASK Study Investigators. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sexspecificity and interactions. Am J Hypertens. 2009;22:332-338. doi: 10.1038/ajh.2008.341.
10. Wagner F, Malice MP, Wiegert E, McGrath HE, Gildea J, Mitta S, Van Dyck K, De Lepeleire I, Johnson-Levonas AO, Sisk CM, Fernandez R, Greenwalt DM, Beals C, Carey RM, Nunes I. A comparison of the natriuretic and kaliuretic effects of cicletanine and hydrochlorothiazide in prehypertensive and hypertensive humans. J Hypertens. 2012;30:819-827. doi: 10.1097/HJH.0b013e32835022a8.
11. Liu C, Xi B. Pooled analyses of the associations of polymorphisms in the GRK4 and EMILIN1 genes with hypertension risk. Int J Med Sci. 2012;9:274-279. doi: 10.7150/ijms.4171.
12. Vandell AG, Lobmeyer MT, Gawronski BE, Langaee TY, Gong Y, Gums JG, Beitelshees AL, Turner ST, Chapman AB, Cooper-DeHoff RM, Bailey KR, Boerwinkle E, Pepine CJ, Liggett SB, Johnson JA. G protein receptor kinase 4 polymorphisms: ?-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension. 2012;60:957-964. doi: 10.1161/HYPERTENSIONAHA.112.198721.
13. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol. 2008;294:H551-H569. doi: 10.1152/ajpheart.01036.2007.
14. Giani JF, Janjulia T, Taylor B, Bernstein EA, Shah K, Shen XZ, McDonough AA, Bernstein KE, Gonzalez-Villalobos RA. Renal generation of angiotensin II and the pathogenesis of hypertension. Curr Hypertens Rep. 2014;16:477. doi: 10.1007/s11906-014-0477-1.
15. Nguyen Dinh Cat A, Touyz RM. Cell signaling of angiotensin II on vascular tone: novel mechanisms. Curr Hypertens Rep. 2011;13:122-128. doi: 10.1007/s11906-011-0187-x.
16. Kemp BA, Howell NL, Gildea JJ, Keller SR, Padia SH, Carey RM. AT2 receptor activation induces natriuresis and lowers blood pressure. Circ Res. 2014;115:388-399. doi: 10.1161/CIRCRESAHA.115.304110.
17. Yang Z, Yu P, Asico LD, Felder RA, Jose PA. Protein phosphatase 2A B56alpha during development in the spontaneously hypertensive rat. Clin Exp Hypertens. 2004;26:243-254.
18. Yu P, Asico LD, Luo Y, Andrews P, Eisner GM, Hopfer U, Felder RA, Jose PA. D1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int. 2006;70:1072-1079. doi: 10.1038/ sj.ki.5001708.
19. Homan KT, Tesmer JJ. Structural insights into G protein-coupled receptor kinase function. Curr Opin Cell Biol. 2014;27:25-31. doi: 10.1016/j. ceb.2013.10.009.
20. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A. 2002;99:3872-3877. doi: 10.1073/pnas.062694599.
21. Premont RT, Macrae AD, Stoffel RH, Chung N, Pitcher JA, Ambrose C, Inglese J, MacDonald ME, Lefkowitz RJ. Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem. 1996;271:6403-6410.
22. Chen K, Fu C, Chen C, Liu L, Ren H, Han Y, Yang J, He D, Zhou L, Yang Z, Zhang L, Jose PA, Zeng C. Role of GRK4 in the regulation of arterial AT1 receptor in hypertension. Hypertension. 2014;63:289-296. doi: 10.1161/HYPERTENSIONAHA.113.01766.
23. Eckhart AD, Ozaki T, Tevaearai H, Rockman HA, Koch WJ. Vasculartargeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol. 2002;61:749-758.
24. Izzo R, Cipolletta E, Ciccarelli M, Campanile A, Santulli G, Palumbo G, Vasta A, Formisano S, Trimarco B, Iaccarino G. Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. Clin Transl Sci. 2008;1:215-220. doi: 10.1111/j.1752-8062.2008.00050.x.
25. Avendaño MS, Lucas E, Jurado-Pueyo M, Martínez-Revelles S, Vila-Bedmar R, Mayor F Jr, Salaices M, Briones AM, Murga C. Increased nitric oxide bioavailability in adult GRK2 hemizygous mice protects against angiotensin II-induced hypertension. Hypertension. 2014;63:369-375. doi: 10.1161/HYPERTENSIONAHA.113.01991.
26. Keys JR, Zhou RH, Harris DM, Druckman CA, Eckhart AD. Vascular smooth muscle overexpression of G protein-coupled receptor kinase 5 elevates blood pressure, which segregates with sex and is dependent on Gi-mediated signaling. Circulation. 2005;112:1145-1153. doi: 10.1161/ CIRCULATIONAHA.104.531657.
27. Oliver E, Rovira E, Montó F, Valldecabres C, Julve R, Muedra V, Ruiz N, Barettino D, D'Ocon P. beta-Adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion. J Hypertens. 2010;28:1281-1289. doi: 10.1097/HJH.0b013e3283383564.
28. Tiberi M, Nash SR, Bertrand L, Lefkowitz RJ, Caron MG. Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J Biol Chem. 1996;271:3771-3778.
29. Fraga S, Luo Y, Jose P, Zandi-Nejad K, Mount DB, Soares-da-Silva P. Dopamine D1-like receptor-mediated inhibition of Cl/HCO3-exchanger activity in rat intestinal epithelial IEC-6 cells is regulated by G proteincoupled receptor kinase 6 (GRK 6). Cell Physiol Biochem. 2006;18:347-360. doi: 10.1159/000097612.
30. Xu J, Watanabe H, Felder RA, Jose PA. GRK6 in the kidney in human and rat genetic hypertension [abstract]. FASEB J. 2001;15:A774.
31. Keever LB, Jones JE, Andresen BT. G protein-coupled receptor kinase 4gamma interacts with inactive Galpha(s) and Galpha13. Biochem Biophys Res Commun. 2008;367:649-655. doi: 10.1016/j.bbrc.2007.12.181.
32. Gurevich EV, Tesmer JJ, Mushegian A, Gurevich VV. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther. 2012;133:40-69. doi: 10.1016/j.pharmthera.2011.08.001.
33. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637-650. doi: 10.1038/ncpneph0301.
34. Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, Watanabe T, Xu J, Luo Y, Wang X, Zeng C, Armando I, Felder RA, Jose PA. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension. 2006;47:1131-1139. doi: 10.1161/01.HYP.0000222004.74872.17.
35. Escano CS, Armando I, Wang X, Asico LD, Pascua A, Yang Y, Wang Z, Lau YS, Jose PA. Renal dopaminergic defect in C57Bl/6J mice. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1660-R1669. doi: 10.1152/ajpregu.00147.2009.
36. Villar VA, Jones JE, Armando I, Palmes-Saloma C, Yu P, Pascua AM, Keever L, Arnaldo FB, Wang Z, Luo Y, Felder RA, Jose PA. G proteincoupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem. 2009;284:21425-21434. doi: 10.1074/jbc.M109.003665.
37. Montasser ME, Shimmin LC, Gu D, et al. Variation in genes that regulate blood pressure are associated with glomerular filtration rate in Chinese. PLoS One. 2014;9:e92468. doi: 10.1371/journal.pone.0092468.
38. Trivedi M, Lokhandwala MF. Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats. Am J Physiol Renal Physiol. 2005;289:F298-F304. doi: 10.1152/ ajprenal.00362.2004.
39. Hasenkamp S, Telgmann R, Staessen JA, Hagedorn C, Dördelmann C, Bek M, Brand-Herrmann SM, Brand E. Characterization and functional analyses of the human G protein-coupled receptor kinase 4 gene promoter. Hypertension. 2008;52:737-746. doi: 10.1161/ HYPERTENSIONAHA.108.114512.
40. Gildea JJ, Tran HT, Van Sciver RE, Bigler Wang D, Carlson JM, Felder RA. A novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells. Hypertension. 2013;61:1021-1027. doi: 10.1161/ HYPERTENSIONAHA.111.00321.
41. Sallese M, Iacovelli L, Cumashi A, Capobianco L, Cuomo L, De Blasi A. Regulation of G protein-coupled receptor kinase subtypes by calcium sensor proteins. Biochim Biophys Acta. 2000;1498:112-121.
42. Villar VA, Armando I, Sanada H, Frazer LC, Russo CM, Notario PM, Lee H, Comisky L, Russell HA, Yang Y, Jurgens JA, Jose PA, Jones JE. Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension. FASEB J. 2013;27:1808-1819. doi: 10.1096/fj.12-208439.
43. Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase Kidney Int. 2002;62:790-798. doi: 10.1046/j.1523-1755.2002.00525.x.
44. Rankin ML, Marinec PS, Cabrera DM, Wang Z, Jose PA, Sibley DR. The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol. 2006;69:759-769. doi: 10.1124/ mol.105.019901.
45. Wang Z, Armando I, Asico LD, Escano C, Wang X, Lu Q, Felder RA, Schnackenberg CG, Sibley DR, Eisner GM, Jose PA. The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol. 2007;292:H2083-H2092. doi: 10.1152/ajpheart.00944.2006.
46. Wang Z, Chen S, Asico LD, Escano CS, Villar VA, Lu Q, Coffman TM, Jones JE, Armando I, Felder RA, Jose PA. AT1R dysregulation is crucial in the hypertension of human GRK4 A142V transgenic mice [abstract]. FASEB J. 2009;23:802.7.
47. Chugh G, Lokhandwala MF, Asghar M. Altered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats. Hypertension. 2012;59:1029-1036. doi: 10.1161/ HYPERTENSIONAHA.112.192302.
48. Yoneda M, Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Sasaki M, Katoh T, Watanabe T, Andrews PM, Jose PA, Felder RA. Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Hypertension. 2005;46:58-65. doi: 10.1161/01.HYP.0000171587.44736.ba.
49. Yatabe J, Sanada H, Midorikawa S, Hashimoto S, Watanabe T, Andrews PM, Armando I, Wang X, Felder RA, Jose PA. Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats. Hypertens Res. 2008;31:1455-1464. doi: 10.1291/ hypres.31.1455.
50. Wang Z, Asico L, Wang X, Escano C, Jose P. Human G protein-coupled receptor kinase type 4? (GRK4?) 486V-promoted salt sensitivity in transgenic mice is related with increased AT1 receptor (AT1R) [abstract]. J Am Soc Nephrol. 2007;18:148A.
51. Lohmueller KE, Wong LJ, Mauney MM, Jiang L, Felder RA, Jose PA, Williams SM. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet. 2006;70(Pt 1):27-41. doi: 10.1111/j.1529-8817.2005.00197.x.
52. Bengra C, Mifflin TE, Khripin Y, Manunta P, Williams SM, Jose PA, Felder RA. Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem. 2002;48:2131-2140.
53. Williams SM, Ritchie MD, Phillips JA III, et al. Multilocus analysis of hypertension: A hierarchical approach. Hum Hered. 2004;57:28-38. doi: 10.1159/000077387.
54. Zhu H, Lu Y, Wang X, Treiber FA, Harshfield GA, Snieder H, Dong Y. The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am J Hypertens. 2006;19:61-66. doi: 10.1016/j.amjhyper.2005.07.007.
55. Carey RM, Schoeffel CD, Gildea JJ, et al. Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension. 2012;60:1359-1366. doi: 10.1161/ HYPERTENSIONAHA.112.196071.
56. Zhu H, Lu Y, Wang X, Snieder H, Treiber FA, Harshfield GA, Dong Y. The G protein-coupled receptor kinase 4 gene modulates stress-induced sodium excretion in black normotensive adolescents. Pediatr Res. 2006;60:440-442. doi: 10.1203/01.pdr.0000238250.64591.44.
57. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH, Ritchie MD, Williams SM, Pezzullo JC, Sasaki M, Eisner GM, Jose PA, Felder RA. Single-nucleotide polymorphisms for diagnosis of saltsensitive hypertension. Clin Chem. 2006;52:352-360. doi: 10.1373/ clinchem.2005.059139.
58. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens. 2004;22:931-936.
59. Wang Y, Li B, Zhao W, Liu P, Zhao Q, Chen S, Li H, Gu D. Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese. Ann Hum Genet. 2006;70(Pt 6):778-783. doi: 10.1111/j.1469-1809.2006.00278.x.
60. Gu D, Su S, Ge D, Chen S, Huang J, Li B, Chen R, Qiang B. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension. 2006;47:1147-1154. doi: 10.1161/01.HYP.0000219041.66702.45.
61. Martinez Cantarin MP, Ertel A, Deloach S, Fortina P, Scott K, Burns TL, Falkner B. Variants in genes involved in functional pathways associated with hypertension in African Americans. Clin Transl Sci. 2010;3:279-286. doi: 10.1111/j.1752-8062.2010.00242.x.
62. Kimura L, Angeli CB, Auricchio MT, Fernandes GR, Pereira AC, Vicente JP, Pereira TV, Mingroni-Netto RC. Multilocus family-based association analysis of seven candidate polymorphisms with essential hypertension in an African-derived semi-isolated brazilian population. Int J Hypertens. 2012;2012:859219. doi: 10.1155/2012/859219.
63. Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, Westerkamp J, Richart T, Thijs L, Li X, Brand-Herrmann SM, Burnier M, Brand E. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension. 2008;51:1643-1650. doi: 10.1161/HYPERTENSIONAHA.107.109611.
64. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O'Connor DT. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007;49:96-106. doi: 10.1161/01.HYP.0000252029.35106.67.
65. Yatabe J, Yatabe MS, Yoneda M, Felder RA, Jose PA, Sanada H. Hypertension-related gene polymorphisms of G-protein-coupled receptor kinase 4 are associated with NT-proBNP concentration in normotensive healthy adults. Int J Hypertens. 2012;2012:806810. doi: 10.1155/2012/806810.
66. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics. 2004;19:233-246. doi: 10.1152/physiolgenomics.00127.2004.
67. Cabrera CP, Ng FL, Warren HR, Barnes MR, Munroe PB, Caulfield MJ. Exploring hypertension genome-wide association studies findings and impact on pathophysiology, pathways, and pharmacogenetics. Wiley Interdiscip Rev Syst Biol Med. 2015;7:73-90. doi: 10.1002/ wsbm.1290.
68. Franceschini N, Chasman DI, Cooper-DeHoff RM, Arnett DK. Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies. Curr Hypertens Rep. 2014;16:461. doi: 10.1007/ s11906-014-0461-9.
69. Natekar A, Olds RL, Lau MW, Min K, Imoto K, Slavin TP. Elevated blood pressure: Our family's fault? The genetics of essential hypertension. World J Cardiol. 2014;6:327-337. doi: 10.4330/wjc.v6.i5.327.
70. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32:3-15. doi: 10.1097/ HJH.0000000000000065.
71. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427.
72. Sanada H, Yatabe J, Yatabe MS, Yokokawa H, Williams S, Bartlett J, Wang Z, Felder R, Jose PA. G Protein-coupled receptor type 4 gene variants and response to antihypertensive medication [Abstract]. Circulation. 2009;120:S1087.
73. Muskalla AM, Suter PM, Saur M, Nowak A, Hersberger M, Krayenbuehl PA. G-protein receptor kinase 4 polymorphism and response to antihypertensive therapy. Clin Chem. 2014;60:1543-1548. doi: 10.1373/ clinchem.2014.226605.